CDT Equity/$CDT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About CDT Equity
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
- Ticker
- $CDT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Naples, United States
- Website
- www.cdtequity.com
CDT Equity Metrics
BasicAdvanced
$29K
-
-
1.69
-
Price and volume
Market cap
$29K
Beta
1.69
52-week high
$1.61
52-week low
$0.45
Financial strength
Current ratio
0.126
Quick ratio
0.039
Total debt to equity
0.011
Interest coverage (TTM)
-166.14%
Profitability
EBITDA (TTM)
-22.833
Management effectiveness
Return on assets (TTM)
-23.43%
Return on equity (TTM)
-69.68%
Valuation
Growth
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.